Bleakley Financial Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$63K 592
2024
Q4
$63K Sell
20,000
-90
-0.4% -$322 ﹤0.01% 1007
2024
Q3
$56.7K Buy
20,090
+9,988
+99% +$22.9K ﹤0.01% 997
2024
Q2
$12.4K Sell
10,102
-267
-3% -$240 ﹤0.01% 1011
2024
Q1
$8.23K Sell
10,369
-705
-6% -$641 ﹤0.01% 995
2023
Q4
$10.5K Hold
11,074
﹤0.01% 946
2023
Q3
$12K Sell
11,074
-15
-0.1% -$18 ﹤0.01% 875
2023
Q2
$9.95K Buy
+11,089
New +$9.84K ﹤0.01% 922

Other funds holding CLOV

Bleakley Financial Group's CLOV Position: Q1 2025 in Review

Bleakley Financial Group sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 20,000 shares — an estimated $63K sold.

Bleakley Financial Group first reported a position in CLOV in Q2 2023 and held it in 7 quarters. The position peaked at $63K in Q4 2024. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Bleakley Financial Group reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 20,000 Clover Health Investments shares in Q1 2025, an estimated $63K.
  • Bleakley Financial Group first reported a position in Clover Health Investments in Q2 2023 and held it in 7 quarters.
  • Bleakley Financial Group's Clover Health Investments position peaked at $63K in Q4 2024.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.